When the two overlap, some people may notice stronger nausea, lower alcohol tolerance, worse hangovers, or less interest in drinking
Phase 1 GLP-1 and GLP-1/GIP receptor agonists should be used as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight maintenance, in: BMI 38 kg/m 2 (or 35 kg/m 2 in ethnic groups known to be at equivalent risk of obesity consequences at lower BMI than White ethnicity), and one or more obesity-related clinical condition, or Edmonton Obesity Staging System stage 3 or 4 (see Box 1
Common but temporary effects on vision Vision changes are a known potential side effect to taking GLP-1 medications
Feeling cold is not listed as an official adverse effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), though some patients report increased cold sensitivity during treatment
Semaglutide withdrawal symptoms apply similarly to tirzepatide: increased appetite, potential weight regain, and sometimes temporary metabolic slowdown
While the drugs have recently surged in popularity, Rothman emphasized they arent new